PL1681059T3 - Kompozycja farmaceutyczna zawierająca prostaglandynę - Google Patents

Kompozycja farmaceutyczna zawierająca prostaglandynę

Info

Publication number: PL1681059T3
Authority: PL; Poland
Prior art keywords: prostaglandin; pharmaceutical composition; composition containing; water; containing prostaglandin
Prior art date: 2003-11-07

Application number

PL04818172T

Other languages

English (en)

Inventor

Yusuke Sakai

Akira Ohtori

Original Assignee

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-07

Filing date

2004-10-26

Publication date

2010-01-29

2004-10-26 Application filed by Senju Pharma Co filed Critical Senju Pharma Co

2010-01-29 Publication of PL1681059T3 publication Critical patent/PL1681059T3/pl

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
150000003180 prostaglandins Chemical class 0.000 title 1
PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 abstract 3
230000015556 catabolic process Effects 0.000 abstract 1
238000006731 degradation reaction Methods 0.000 abstract 1
150000004667 medium chain fatty acids Chemical class 0.000 abstract 1
239000007764 o/w emulsion Substances 0.000 abstract 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
229920003169 water-soluble polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL04818172T 2003-11-07 2004-10-26 Kompozycja farmaceutyczna zawierająca prostaglandynę PL1681059T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2003378196		2003-11-07
EP04818172A EP1681059B1 (en)	2003-11-07	2004-10-26	Pharmaceutical composition containing prostaglandin
PCT/JP2004/015828 WO2005044276A1 (ja)	2003-11-07	2004-10-26	プロスタグランジン含有医薬組成物

Publications (1)

Publication Number	Publication Date
PL1681059T3 true PL1681059T3 (pl)	2010-01-29

Family

ID=34567167

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04818172T PL1681059T3 (pl)	2003-11-07	2004-10-26	Kompozycja farmaceutyczna zawierająca prostaglandynę

Country Status (10)

Country	Link
US (2)	US20080139652A1 (pl)
EP (1)	EP1681059B1 (pl)
JP (1)	JP4762718B2 (pl)
KR (1)	KR101091461B1 (pl)
CN (1)	CN100484528C (pl)
AT (1)	ATE442146T1 (pl)
DE (1)	DE602004023106D1 (pl)
ES (1)	ES2331313T3 (pl)
PL (1)	PL1681059T3 (pl)
WO (1)	WO2005044276A1 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2578176C (en)	2004-11-09	2013-09-24	Novagali Pharma Sa	Ophthalmic emulsions containing an immunosuppressive agent
ATE485479T1 (de)	2005-03-31	2010-11-15	Neobulb Technologies Inc	Hochleistungs-led-beleuchtungseinrichtung mit hohem thermischen diffusionsvermögen
US8030349B2 (en) *	2005-08-02	2011-10-04	Santen Pharmaceutical Co., Ltd.	Method for prevention of degradation of thermally unstable medicament
JP5122460B2 (ja) *	2005-09-16	2013-01-16	アラーガン、インコーポレイテッド	治療薬の眼内輸送のための組成物および方法
CN101282714B (zh) *	2005-10-10	2012-12-12	诺瓦加利制药公司	包含前列腺素的眼用乳剂
WO2007105691A1 (ja) *	2006-03-13	2007-09-20	R-Tech Ueno, Ltd.	水性組成物
DE102006049091A1 (de) *	2006-10-18	2008-04-24	Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh	Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl
EP2123278B1 (en)	2007-02-07	2013-01-09	Teika Pharmaceutical Co., Ltd.	Eye drop preparation comprising latanoprost
EP1985298A1 (en) *	2007-04-24	2008-10-29	Azad Pharma AG	Ophtalmic oil-in-water emulsions containing prostaglandins
FR2916636B1 (fr) *	2007-05-29	2009-09-04	Octalia Technologies	Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
EP2172202A4 (en)	2007-06-29	2010-06-30	Taisho Pharmaceutical Co Ltd	A PROSTAGLAND DERIVATIVE CONTAINING AQUEOUS LIQUID MEDIUM
JP2009073788A (ja) *	2007-09-21	2009-04-09	Teika Seiyaku Kk	イソプロピルウノプロストン含有眼用組成物
TW201010708A (en) *	2008-06-02	2010-03-16	Intervet Int Bv	Composition comprising an antibiotic and a corticosteroid
FR2938757B1 (fr) *	2008-11-27	2010-12-31	Octalia Technologies	Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique
EP2228058A1 (en) *	2009-03-04	2010-09-15	Novagali Pharma S.A.	Anionic oil-in-water emulsion containing prostaglandins and uses thereof
NZ716349A (en)	2009-11-09	2017-07-28	Allergan Inc	Compositions and methods for stimulating hair growth
US20110112198A1 (en) *	2009-11-09	2011-05-12	Allergan, Inc.	Compositions for enhancing hair growth
EP2389939A1 (en)	2010-05-28	2011-11-30	Novagali Pharma S.A.	Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
IT1404931B1 (it) *	2010-06-11	2013-12-09	Medivis S R L	Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
CA2837240A1 (en) *	2011-05-27	2012-12-06	Ratiopharm Gmbh	Ophthalmic preparation comprising a pgf2.alpha. analogue
US9278132B2 (en) *	2012-02-13	2016-03-08	Bausch & Lomb Incorporated	Ophthalmic pharmaceutical compositions and methods of making and using same
EP2956096A1 (en)	2013-02-15	2015-12-23	Allergan, Inc.	Sustained drug delivery implant
EP3520778B1 (en)	2016-11-17	2024-04-10	Senju Pharmaceutical Co., Ltd.	Emulsion eyedrops
KR20200035047A (ko) *	2017-08-03	2020-04-01	산텐 세이야꾸 가부시키가이샤	클로르헥시딘을 함유하는 의약 조성물
KR102365008B1 (ko) *	2020-06-23	2022-02-23	주식회사태준제약	디쿠아포솔을 포함하는 점안 조성물
CN115400074A (zh) *	2021-05-27	2022-11-29	山东新时代药业有限公司	拉坦前列素滴眼液及其制备方法
CN115463088A (zh) *	2021-06-11	2022-12-13	温士顿医药股份有限公司	含前列腺素衍生物的眼用纳米乳剂组合物
WO2024015959A1 (en)	2022-07-15	2024-01-18	Praful Doshi	Methods of making and using contact lenses including medicaments and stabilizers of labile components such as drugs

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2714065A1 (de) *	1977-03-30	1978-10-12	Boehringer Mannheim Gmbh	Instillationszubereitung
JPS6051105A (ja) *	1983-08-30	1985-03-22	Green Cross Corp:The	プロスタグランジン脂肪乳剤
CA1324129C (en)	1987-04-30	1993-11-09	Ryuzo Ueno	Prostaglandins of the f series
US4839371A (en) *	1987-09-17	1989-06-13	Smithkline Beckman Corporation	3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors
GB2209939B (en) *	1987-09-18	1992-01-02	R Tech Ueno Ltd	The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
US5192535A (en)	1988-02-08	1993-03-09	Insite Vision Incorporated	Ophthalmic suspensions
JP2597629B2 (ja) *	1988-02-26	1997-04-09	株式会社上野製薬応用研究所	１３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
DE68929435T2 (de) *	1988-09-06	2003-07-17	Pharmacia Ab, Stockholm	Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
US5296504A (en) *	1988-09-06	1994-03-22	Kabi Pharmacia	Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
JPH0710833A (ja)	1991-04-16	1995-01-13	Yutaka Mizushima	プロスタグランジン類縁体、その脂肪乳剤およびその用途
US5352708A (en) *	1992-09-21	1994-10-04	Allergan, Inc.	Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) *	1993-08-03	1996-04-23	Alcon Laboratories, Inc.	Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5631287A (en) *	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
US5767153A (en)	1995-06-07	1998-06-16	Insite Vision Incorporated	Sustained release emulsions
US5767135A (en) *	1995-12-29	1998-06-16	Fernandez-Pol; Jose Alberto	Antiviral agent
US6066671A (en) *	1997-12-19	2000-05-23	Alcon Laboratories, Inc.	Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
JP4421699B2 (ja)	1999-06-30	2010-02-24	大洋薬品工業株式会社	静脈注射可能なプロスタグランジン脂肪乳剤
US20020013294A1 (en) *	2000-03-31	2002-01-31	Delong Mitchell Anthony	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
PT1321144E (pt) *	2000-09-13	2011-03-10	Santen Pharmaceutical Co Ltd	Colírio
JP3876355B2 (ja)	2000-09-13	2007-01-31	参天製薬株式会社	点眼液
US6635654B1 (en) *	2003-01-09	2003-10-21	Allergan, Inc.	Ophthalmic compositions containing loratadine

2004
- 2004-10-26 DE DE602004023106T patent/DE602004023106D1/de not_active Expired - Lifetime
- 2004-10-26 AT AT04818172T patent/ATE442146T1/de not_active IP Right Cessation
- 2004-10-26 WO PCT/JP2004/015828 patent/WO2005044276A1/ja not_active Ceased
- 2004-10-26 KR KR1020067010544A patent/KR101091461B1/ko not_active Expired - Fee Related
- 2004-10-26 US US10/573,191 patent/US20080139652A1/en not_active Abandoned
- 2004-10-26 JP JP2005515261A patent/JP4762718B2/ja not_active Expired - Fee Related
- 2004-10-26 PL PL04818172T patent/PL1681059T3/pl unknown
- 2004-10-26 ES ES04818172T patent/ES2331313T3/es not_active Expired - Lifetime
- 2004-10-26 EP EP04818172A patent/EP1681059B1/en not_active Expired - Lifetime
- 2004-10-26 CN CNB2004800315504A patent/CN100484528C/zh not_active Expired - Fee Related
2011
- 2011-08-10 US US13/206,784 patent/US8697751B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1681059A4 (en)	2007-10-10
US20110294880A1 (en)	2011-12-01
JP4762718B2 (ja)	2011-08-31
KR101091461B1 (ko)	2011-12-07
ATE442146T1 (de)	2009-09-15
EP1681059A1 (en)	2006-07-19
CN1871014A (zh)	2006-11-29
KR20060123215A (ko)	2006-12-01
WO2005044276A1 (ja)	2005-05-19
JPWO2005044276A1 (ja)	2007-05-17
US20080139652A1 (en)	2008-06-12
DE602004023106D1 (de)	2009-10-22
ES2331313T3 (es)	2009-12-29
EP1681059B1 (en)	2009-09-09
CN100484528C (zh)	2009-05-06
US8697751B2 (en)	2014-04-15

Publication	Publication Date	Title
EP1681059A4 (en)	2007-10-10	PHARMACEUTICAL COMPOSITION CONTAINING PROSTAGLANDIN
EA200801602A1 (ru)	2009-02-27	Эмульсия
KR890011586A (ko)	1989-08-21	지용성물질의 수용액
WO2006052664A3 (en)	2006-07-20	Processes for preparation of oil compositions
WO2003028451A3 (en)	2004-03-18	Microbiocidal formulation comprising essential oils or their derivatives
EA201170433A1 (ru)	2011-10-31	Полисахаридная капсула, включающая в себя эмульсию, содержащую масло жирных кислот
CR7999A (es)	2006-05-29	Metodos y composiciones farmaceuticas para la obtencion confiable de niveles aceptables de testosterona en suero
EP1546296A4 (en)	2005-09-14	Protection of fragrance in a wax candle using an antioxidants
AR032200A1 (es)	2003-10-29	Productos antitranspirantes
EA201201380A1 (ru)	2013-04-30	Термически стабильные эмульсии "масло-в-воде", содержащие масло, которое содержит полиненасыщенные жирные кислоты
BR112020019776A2 (pt)	2021-01-05	Uso inovador de croman-6-óis substituídos
CL2008001180A1 (es)	2009-01-16	Un polvo bebestible instantaneo que comprende un agente de relleno y/o azucar recubiertas al menos parcialmente con un 0,1-5% de aceite de cadenas cortas de acidos grasos saturados de trigleceridos saturados c4-c14; capsula que comprende el polvo bebestible; metodo de produccion del polvo; kit que comprende un polvo bebestible.
BRPI0705244A (pt)	2008-05-20	composição oleosa de ácido linolênico conjugado
GB2459809A (en)	2009-11-11	Fatty acid formulations and methods of use thereof
BRPI0413845A (pt)	2006-10-24	antioxidante que é baseado em ácido ascórbico, uso do antioxidante, e, preparação de gordura alimentìcia ou óleo alimentìcio
BRPI0413491A (pt)	2006-10-17	sistema de gordura vegetal hidrogenada
BRPI0408849B8 (pt)	2016-05-24	agente de modificação de carne, método de produção de produto de carne e produto de carne
CH700328B8 (de)	2010-10-15	O/W-Emulsion zur Pflege der Hand.
WO2008143090A1 (ja)	2008-11-27	油中水型乳化組成物
BR0306964A (pt)	2004-12-14	Composições isotrópicas transparentes contendo vitamina lipossolúvel
DE602005019207D1 (de)	2010-03-18	Orale zusammensetzung zur verbesserung der hauteigenschaften
EA200800148A1 (ru)	2008-06-30	Применение фуллерена с60 в качестве стабилизатора масел
DE602006018778D1 (de)	2011-01-20	Mayonnaiseprodukt und verfahren zu seiner herstellung
ATE549943T1 (de)	2012-04-15	Verfahren zur herstellung von sojasaucenpulver
PE20041063A1 (es)	2005-03-07	Composicion farmaceutica que comprende acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico